Contribution of Rare Large High-Penetrance CNVs to Pediatric and MODY Diabetes in Norway
Haydeé Artaza, Divya Sri Priyanka Tallapragada, Janne Molnes, Ksenia Lavrichenko, Anette S. B. Wolff, Ellen Christine Røyrvik, Torild Skrivarhaug, Marc Vaudel, Eirik Bratland, Bente Berg Johansson, Pål R. Njølstad, Stefan Johansson
The paper identifies rare, large, high-penetrance CNVs in Norwegian pediatric diabetes and MODY patients, finding 0.63% and 0.09% of cases attributable to pathogenic deletions, with some undetected by standard methods.
medRxiv · Feb 25, 2025 · PreprintGenetic & Genomic Medicine